NCT06848946 - Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions

Glaucoma, Open-angleOcular Hypertension (OHT)Phacoemulsification Cataract Surgery

Interventions

COMBINATION_PRODUCT

iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery

PROCEDURE

Sham procedure in conjunction with cataract surgery

Trial Locations (1)

RECRUITING

Glaukos Investigator Site, Kenosha